Revenue: The sum of all revenue fields included for a company's operating activities.
Achilles Therapeutics PLC Sponsored ADR (ACHL) Revenue data is not available.
Income Statement Financials | |
Revenue |
-- |
$-19.59M |
|
-- |
|
-- |
|
$20.42M |
|
$-20.42M |
|
$0.82M |
|
$-19.60M |
|
$-19.60M |
|
$-19.59M |
|
$-19.59M |
|
$-19.59M |
|
$-19.59M |
|
$-20.42M |
|
$-19.22M |
|
40.43M |
|
40.43M |
|
$-0.48 |
|
$-0.48 |
|
Balance Sheet Financials | |
$111.62M |
|
$5.83M |
|
$11.05M |
|
$122.68M |
|
$18.47M |
|
-- |
|
$1.07M |
|
$19.54M |
|
$103.14M |
|
$103.14M |
|
$103.14M |
|
41.10M |
|
Cash Flow Statement Financials | |
$-49.08M |
|
$-0.76M |
|
$0.01M |
|
$131.57M |
|
$86.07M |
|
$-45.50M |
|
$3.88M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
6.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-49.83M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.00% |
|
-19.00% |
|
-15.97% |
|
-19.00% |
|
$2.51 |
|
$-1.23 |
|
$-1.21 |